Displaying 1 to 2 of 2 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Ajax Therapeutics Inc Blood cancer biotech. |
United States | 13 May 2024 | Series C Initial investment. Led the investment round. Active |
|
|
Littlejohn & Co LLC Private equity firm |
United States | 18 Aug 2016 | Private Equity Acquisition of a minority stake., Active |